Kai-chun Wang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High Burden of Coinfection in Systemic Lupus Erythematosus with Bronchoalveolar Lavage Confirmed Pneumocystis jirovecii Pneumonia: A Single-Center Retrospective Study.
Journal: Modern rheumatology
Published: December 12, 2025
House dust mite allergy exacerbates psoriasis by promoting hyperactivation of mast cells and Th17 cells.
Journal: International immunopharmacology
Published: April 16, 2025
RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888.
Journal: Journal of personalized medicine
Published: December 31, 2024
Brevilin A inhibits IL‑17A‑induced inflammation in psoriasis by modulating HSP 70.
Journal: Molecular medicine reports
Published: September 05, 2024
Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.
Journal: Immunopharmacology and immunotoxicology
Published: December 07, 2023
Increased risk of malignancy in HLA-B27-positive patients with ankylosing spondylitis requiring biologics for sustained inflammation: A long-term, single-center retrospective study.
Journal: Modern rheumatology
Published: June 29, 2023
Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment.
Journal: International journal of molecular sciences
Published: June 06, 2023
RETRACTED: Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients.
Journal: Journal of personalized medicine
Published: September 22, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026